No photo of Kalliopi P Siziopikou

View Scopus Profile

Kalliopi P Siziopikou

  • 2106 Citations
1990 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.

Certifications and Licenses

Anatomic Pathology

Training Experience

1994Residency, Beth Israel Deaconess Medical Center, Boston
1995Fellowship, Beth Israel Deaconess Medical Center, Boston

Education/Academic qualification

PhD, Rush Medical Collage

… → 1990

MD, Aristotle University of Thessaloniki

… → 1985

Research interests

  • Breast Cancer
  • Breast Disease
  • Cancer Biology
  • Pathology

Fingerprint Dive into the research topics where Kalliopi P Siziopikou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis

Cheng, C., Cheng, S. & Siziopikou, K. P.

National Cancer Institute

2/4/14 → 5/31/16

Project: Research project

Research Output

The PD-1/PD-L1 Axis in HER2+ Ductal Carcinoma In Situ (DCIS) of the Breast

Ubago, J. M., Blanco, L. Z., Shen, T. & Siziopikou, K. P., Jul 5 2019, In : American journal of clinical pathology. 152, 2, p. 169-176 8 p.

Research output: Contribution to journal › Article

    • 3 Scopus citations

    Double-equivocal HER2 invasive breast carcinomas: Institutional experience and review of literature

    Griffin, B. B., Pincus, J. L., Siziopikou, K. P. & Blanco, L. Z., Dec 2018, In : Archives of Pathology and Laboratory Medicine. 142, 12, p. 1511-1516 6 p.

    Research output: Contribution to journal › Article

    • Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy

    Jain, S., Shah, A. N., Santa-Maria, C. A., Siziopikou, K., Rademaker, A., Helenowski, I., Cristofanilli, M. & Gradishar, W. J., Sep 1 2018, In : Breast Cancer Research and Treatment. 171, 2, p. 371-381 11 p.

    Research output: Contribution to journal › Article

    • 18 Scopus citations

    IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity

    Chiang, S., Weigelt, B., Wen, H. C., Pareja, F., Raghavendra, A., Martelotto, L. G., Burke, K. A., Basili, T., Li, A., Geyer, F. C., Piscuoglio, S., Ng, C. K. Y., Jungbluth, A. A., Balss, J., Pusch, S., Baker, G. M., Cole, K. S., Von Deimling, A., Batten, J. M., Marotti, J. D. & 13 others, Soh, H. C., McCalip, B. L., Serrano, J., Lim, R. S., Siziopikou, K. P., Lu, S., Liu, X., Hammour, T., Brogi, E., Snuderl, M., Iafrate, A. J., Reis-Filho, J. S. & Schnitt, S. J., Dec 15 2016, In : Cancer Research. 76, 24, p. 7118-7129 12 p.

    Research output: Contribution to journal › Article

    • 30 Scopus citations

    Phyllodes tumours of the breast: A consensus review

    Tan, B. Y., Acs, G., Apple, S. K., Badve, S., Bleiweiss, I. J., Brogi, E., Calvo, J. P., Dabbs, D. J., Ellis, I. O., Eusebi, V., Farshid, G., Fox, S. B., Ichihara, S., Lakhani, S. R., Rakha, E. A., Reis-Filho, J. S., Richardson, A. L., Sahin, A., Schmitt, F. C., Schnitt, S. J. & 5 others, Siziopikou, K. P., Soares, F. A., Tse, G. M., Vincent-Salomon, A. & Tan, P. H., Jan 1 2016, In : Histopathology. 68, 1, p. 5-21 17 p.

    Research output: Contribution to journal › Review article

    • 111 Scopus citations